MARATTO

article · East and Central African Journal of Pharmaceutical Sciences

Quality evaluation of ciprofloxacin, metronidazole, albendazole tablets and amoxicillin suspension, marketed in Mwanza, Tanzania: A cross sectional study

Abstract

In Tanzania, essential medicines like amoxicillin, ciprofloxacin, metronidazole, and albendazole face potential quality challenges due to the risk of substandard and falsified drugs in the market. This study was carried out in Mwanza town, Tanzania to assess the quality of these drugs in order to address concerns about antimicrobial resistance and public safety. For this purpose, physical parameters, assay, and dissolution tests were conducted on samples of various brands according to the USP and BP monographs. All samples met USP standards for physical parameters and assay. But one brand of amoxicillin suspension failed assay test. Ciprofloxacin met dissolution criteria, but only one albendazole sample complied. About 47.6% of samples failed the quality tests performed. These results provide vital insights into pharmaceutical quality, safety and efficacy in the study area.

Research topics

  • Pharmaceutical Economics and Policy
  • Pharmaceutical Quality and Counterfeiting
  • Pharmaceutical Practices and Patient Outcomes

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4314/ecajps.v25i3.3

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.